Filtros de búsqueda

Lista de obras de Omar Eton

A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy

scientific article published on 01 April 2000

A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer.

artículo científico publicado en 2009

A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.

artículo científico publicado en 2009

Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma ⬇️

artículo científico publicado el 1 de marzo de 1998

Analysis of protein tyrosine kinase expression in melanocytic lesions by tissue array

artículo científico publicado en 2003

Analysis of protein tyrosine kinases expression in the melanoma metastases of patients treated with Imatinib Mesylate (STI571, Gleevec)

scientific article published on 01 April 2006

Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma

artículo científico publicado en 2010

Biochemotherapy in patients with metastatic anorectal mucosal melanoma.

artículo científico publicado en 2004

Changes in pERK1/2 and pAKT expression in melanoma lesions after imatinib treatment

scientific article published on August 2008

Chemotherapy, cytokines, and biochemotherapy for melanoma

artículo científico publicado en 2005

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system

artículo científico publicado en 1997

Cutaneous melanoma

scientific article published on 01 January 1992

DNA damage in peripheral blood mononuclear cells correlates with response to biochemotherapy in melanoma.

artículo científico publicado en 1998

Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experience

artículo científico publicado el 1 de diciembre de 1997

Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma ⬇️

artículo científico publicado el 1 de mayo de 1998

Enhancement of cell-mediated immunity in melanoma patients immunized with murine anti-idiotypic monoclonal antibodies (MELIMMUNE) that mimic the high molecular weight proteoglycan antigen ⬇️

artículo científico publicado el 1 de octubre de 1998

Establishment and characterization of two human myeloma cell lines secreting kappa light chains.

artículo científico publicado en 1989

Evaluation of interleukin-2 administered by continuous infusion in patients with metastatic melanoma

scientific article published on 01 January 1996

Hypercalcemia due to parathyroid hormone-related protein secretion by melanoma.

artículo científico publicado en 1998

Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo

artículo científico publicado en 2004

Increase in the ability of human cancer cells to induce cytotoxic T lymphocytes by ultraviolet irradiation

artículo científico publicado en 1993

Interleukin-1 production in tumor cells of human melanoma surgical specimens

artículo científico publicado en 1995

Intermittent Dosing of Dabrafenib and Trametinib in Metastatic BRAFV600E Mutated Papillary Thyroid Cancer: Two Case Reports.

artículo científico publicado en 2017

Mechanism of the anti-tumour effect of biochemotherapy in melanoma: preliminary results

scientific article published on 01 October 1994

Melanoma brain metastasis: overview of current management and emerging targeted therapies.

artículo científico

Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacy

scientific article published on 01 May 2006

Nitric oxide and neopterin levels and clinical response in stage III melanoma patients receiving concurrent biochemotherapy

artículo científico publicado en 1998

Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors

artículo científico publicado en 2010

Phase I Study of the Selective Aurora A Kinase Inhibitor MLN8054 in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, and Pharmacodynamics

scientific article published on 19 August 2010

Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma

artículo científico publicado en 2002

Phase II evaluation of bryostatin-1 in metastatic melanoma

artículo científico publicado en 2001

Phase II evaluation of paclitaxel by short intravenous infusion in metastatic melanoma

scientific article published on 01 February 2004

Phase II evaluation of temozolomide in metastatic choroidal melanoma

artículo científico publicado en 2003

Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases

artículo científico publicado en 1998

Phase II trial of 9-nitrocamptothecin (RFS 2000) for patients with metastatic cutaneous or uveal melanoma

artículo científico publicado en 2002

Phase II trial of N-methylformamide in patients with metastatic melanoma

artículo científico publicado en 1991

Phase II trial of cisplatin and etoposide in patients with metastatic melanoma

artículo científico publicado en 1991

Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy

scientific article published on 01 December 1995

Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy

scientific article published on 01 September 1999

Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanoma

artículo científico publicado en 1999

Phase II trial of imatinib mesylate in patients with metastatic melanoma.

artículo científico publicado en 2008

Phase II trial of recombinant human interleukin-2 and interferon-alpha-2a: implications for the treatment of patients with metastatic melanoma

artículo científico publicado en 1996

Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma

artículo científico publicado en 1997

Phase Ia/Ib trial of anti-GD2 chimeric monoclonal antibody 14.18 (ch14.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanoma

scientific article published on 01 May 1996

Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma

artículo científico publicado en 2004

Pilot study of intra-arterial cisplatin and intravenous vinblastine and dacarbazine in patients with melanoma in-transit metastases

scientific article published on 01 October 1999

Prognostic factors for survival of patients treated systemically for disseminated melanoma ⬇️

artículo científico publicado el 1 de marzo de 1998

Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial.

artículo científico publicado en 2002

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

artículo científico publicado en 2014

Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alpha

artículo científico publicado en 1996

Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy

scientific article published on 01 October 2000

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda